HCAT vs ORCL
HCAT: A healthcare intelligence company providing AI-driven technology and professional services to help health systems derive actionable, measurable clinical and financial improvements from their data. ORCL: Oracle is a major enterprise technology powerhouse shifting its massive software footprint to a high-growth, AI-driven cloud infrastructure and applications platform.
Side-by-side fundamentals
| Metric | HCAT | ORCL | Edge |
|---|---|---|---|
| Price as of 2026-10-20 close | $1.75 | $131.14 | |
| Market cap | $132M | $396.5B | |
| P/E as of 2026-10-20 | n/a | 20.55 | |
| PEG as of 2026-10-20, 3-year EPS CAGR to FY2026 | n/a | 0.86 | |
| Net margin | -57.2% | +25.4% | ORCL higher |
| Operating margin | -51.7% | +30.6% | ORCL higher |
| ROE | -72.4% | +39.7% | ORCL higher |
| ROA | -35.4% | +6.5% | ORCL higher |
| Debt / equity filed borrowings, leases excl., balance sheet 2026-06-30 | 1.52 | n/a | |
| Revenue growth (YoY) | +1.5% | +17.4% | ORCL higher |
| Revenue CAGR (3y) SEC XBRL | +4.0% | +10.5% | ORCL higher |
| Dividend yield as of 2026-09-02 | n/a | +1.4% | |
| Dividend streak (yrs) SEC XBRL | 0 | 18 | ORCL higher |
| Beta as of 2026-09-03 | 1.33 | 1.72 | |
| 1-year return as of 2026-10-20 close | -43.9% | -52.7% | HCAT higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.